COVID-19 Resources ▸▸

Turning Innovation Into Enterprise


Dr. David Scholl, Former CEO of Athens, OH-based Diagnostic Hybrids, Inc. to Keynote WV Bio Summit

Dr. David Scholl

Dr. David Scholl

Dr. David Scholl, a southeastern Ohio entrepreneur familiar with the challenges and opportunities associated with biotech development in Appalachia, will share his experiences gleaned over 27+ years of both growing and successfully exiting a life science firm in the region and serving as a partner in the Athens, Ohio-based venture capital firm, Athenian Venture Partners, during the 2013 WV Bioscience Summit.

The event will take place from 8:00 a.m. – 4:00 p.m., on February 28, at the Charleston Town Center Marriott Hotel, in Charleston, West Virginia.  A pre-conference reception will take place at 6:00 p.m. on Feb. 27 at the Charleston Marriott Hotel.  To register for the event, click here.

Dr. Scholl will tell the story of building Diagnostic Hybrids from a four-person startup in the early 1980’s, to becoming a member of the Inc. 500 list of the fastest growing, privately-held companies in the nation, and a world leader in cell-based and Monoclonal Antibody-based diagnostics. Scholl will highlight the challenges the company faced as it rose through the various stages of development – from incubation, technology development, commercialization, fundraising and marketing – through exit.

Dr. Scholl will focus on state assistance and programming – like the Ohio Third Frontier – that have been established to nurture the development of such strategic industry sectors in Ohio as the life science industry.  The Ohio Third Frontier is a $2.3 billion initiative that provides funding and substantial leverage to Ohio technology-based companies, universities, nonprofit research institutions, and other organizations to create new technology-based products, companies, industries, and jobs. In addition to grants directly to companies, this program includes effective pre-seed and seed capital formation strategies to further develop the ecosystem of support throughout all phases of life science development.

Dr. Scholl’s presentation will provide lessons learned and development strategies for life science companies in West Virginia and focus a lens on the actions industry stakeholders – researchers, universities, bioscience firms, economic developers and policy  makers – can take to grow the bioscience industry from within.

Registration Is Open!

Registration for the 2013 West Virginia Bioscience Summit is now open!  Click here to register for what promises to be an exciting look at West Virginia’s life science industries, strategies for growing university research and company development, and the benefits the industries provide to our state.